ֱ

Meeting Coverage

ECTRIMS Future Focus

Developing a Consensus on Smoldering MS

Experts aim to develop a deeper understanding of what smoldering disease entails

image

Latest ECTRIMS Future Focus Meeting Coverage

New Data on CD40 Ligand Inhibitor for Relapsing MS

Novel agent led to sustained reduction of new lesions at 24 weeks

November 14, 2023
Multiple Sclerosis: Treat Early With High-Efficacy Therapy

Stephen Hauser, MD, discusses the second portion of his plenary session

November 7, 2023
Multiple Sclerosis: Paving the Way to a Cure

Advances in MS are a great success story in modern medicine, says Stephen Hauser, MD

October 31, 2023